Results from the UPITA-Colitis Registry on the Effectiveness and Safety of Upadacitinib in the Induction phase in Patients with Ulcerative Colitis

被引：0
|
作者：
Caballero Mateos, A. M. [1 ]
Gonzalez-Parra, A. C. [2 ]
Gutierrez-Holanda, C. [3 ]
Trapero-Martinez, A. M. [4 ]
Hernandez-Martinez, A. [5 ]
Rojas-Feria, M. [6 ]
Martin-Rodriguez, M. D. M. [7 ]
Rodriguez-Gonzalez, F. J. [8 ]
Saldana, L. [9 ]
Benitez, J. M. [10 ]
Gomez-Delgado, E. [11 ]
Miras, L. [12 ]
Gonzalez, J. [13 ]
Mata, F. J. [14 ]
Olmedo-Martin, R., V [15 ]
GATE, II
机构：
[1] Santa Ana Hosp, Gastroenterol, Motril Granada, Spain
[2] Virgen Macarena Univ Hosp, Gastroenterol, Seville, Spain
[3] San Cecilio Universityl Hosp, Gastroenterol, Granada, Spain
[4] Univ Hosp, Gastroenterol, Jaen, Spain
[5] Torrecardenas Univ Hosp, Gastroenterol, Almeria, Spain
[6] Virgen Rocio Univ Hosp, Gastroenterol, Seville, Spain
[7] Virgen Nieves Univ Hosp, Gastroenterol, Granada, Spain
[8] Virgen Victoria Univ Hosp, Gastroenterol, Malaga, Spain
[9] Costa Sol Hosp, Gastroenterol, Marbella, Spain
[10] Reina Sofia Univ Hosp, Gastroenterol, Cordoba, Spain
[11] Juan Ramon Jimenez Hosp, Gastroenterol, Huelva, Spain
[12] El Poniente Hosp, Gastroenterol, El Ejido, Sri Lanka
[13] Inmaculada Hosp, Gastroenterol, Huercal Overa, Spain
[14] Puerto Real Hosp, Gastroenterol, Puerto Real, Spain
[15] Reg Hosp, Gastroenterol, Malaga, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1284
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1110
引用
收藏
页码：i2042 / i2044
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
    Vermeire, S.
    Danese, S.
    Zhou, W.
    Pangan, A.
    Greenbloom, S.
    D'Haens, G.
    Panes, J.
    Juillerat, P.
    Lindsay, J. O.
    Loftus, E. V., Jr.
    Sandborn, W. J.
    Reinisch, W.
    Gonzalez, Y. Sanchez
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M. A.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S021 - S022
  • [2] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
    Danese, S.
    Vermeire, S.
    Zhou, W.
    Pangan, A.
    Siffledeen, J.
    Hebuterne, X.
    Nakase, H.
    Higgins, P.
    Chen, M. H.
    Sanchez-Gonzalez, Y.
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M.
    Pannaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024
  • [3] Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Pangan, Aileen
    Greenbloom, Susan
    D'Haens, Geert
    Panes, Julian
    Juillerat, Pascal
    Lindsay, James
    Loftus, Edward V.
    Sandborn, William
    Reinisch, Walter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S357 - S357
  • [4] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study
    Danese, Silvio
    Vermeire, Severine
    Zhou, Wen
    Pangan, Aileen
    Siffledeen, Jesse
    Hebuterne, Xavier
    Nakase, Hiroshi
    Chen, Minhu
    Higgins, Peter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313
  • [5] Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry
    Straatmijer, Tessa
    van Schaik, Fiona D. M.
    Bodelier, Alexander G. L.
    Visschedijk, Marijn
    de Vries, Annemarie C.
    Ponsioen, Cyriel Y.
    Pierik, Marieke
    van Bodegraven, Ad A.
    West, Rachel L.
    de Boer, Nanne K. H.
    Srivastava, Nidhi
    Romkens, Tessa E. H.
    Hoekstra, Jildou
    Oldenburg, Bas
    Dijkstra, Gerard
    van der Woude, Janneke C.
    Lowenberg, Mark
    Mujagic, Zlatan
    Biemans, Vince B. C.
    Van der Meulen-de Jong, Andrea E.
    Duijvestein, Marjolijn
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 117 - 126
  • [6] REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN ULCERATIVE COLITIS: A MULTICENTER STUDY
    Patel, Anish
    Johnson, Amanda M.
    Berinstein, Jeffrey
    Dulaney, David
    Fenster, Marc
    Ayoub, Malek
    Huang, Katherine
    Lieto, Stephen
    Scalzo, Nicholas
    Loftus, Edward V.
    Higgins, Peter D.
    Chowla, Navreet M.
    Reddy, Nikhil
    Yarur, Andres
    Kuang, Andrew
    Shukla, Richa
    Sekhri, Shaina
    Pekow, Joel
    Beniwal-Patel, Poonam
    Cohen, Benjamin L.
    Gutierrez, Alexandra
    Colombel, Jean Frederic
    Ciorba, Matthew A.
    Bishu, Shrinivas
    Ungaro, Ryan C.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2023, 164 (06) : S1136 - S1137
  • [7] Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience
    Berinstein, Jeffrey A.
    Karl, Taylor
    Patel, Anish
    Dolinger, Michael
    Barrett, Terrence A.
    Ahmed, Waseem
    Click, Ben
    Steiner, Calen A.
    Dulaney, David
    Levine, Jake
    Hassan, Syed Adeel
    Perry, Courtney
    Flomenhoft, Deborah
    Ungaro, Ryan C.
    Berinstein, Elliot M.
    Sheehan, Jessica
    Cohen-Mekelburg, Shirley
    Regal, Randolph E.
    Stidham, Ryan W.
    Bishu, Shrinivas
    Colombel, Jean-Frederic
    Higgins, Peter D. R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (07): : 1421 - 1425
  • [8] Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA
    Chaparro, M.
    Hermida, S.
    Martin, L. Zabalza San
    Cuquerella, J. Tosca
    de Castro, L.
    Dominguez, C. Larrubia
    Rodriguez-Lago, I.
    Castro, C. Reygosa
    Trastoy, P. Varela
    Gargallo-Puyuelo, C. J.
    Abadia, P. Ripoll
    Ruiz-Cerulla, A.
    Barreiro-de Acosta, M.
    de Francisco, R.
    Gutierrez, A.
    Jimenez, N.
    Villarroya, R. Pajares
    Bujanda, L.
    Martinez, A. M. Trapero
    Garcia, L. Arias
    Camero, R. Camargo
    Calafat, M.
    Palomares, M. T. Diz-Lois
    Andres, P. Robledo
    Sampedro, M. J.
    Nieto, Y. Ber
    Bermejo, F.
    Moya, M. Calvo
    Casanova, M. J.
    Ceballos, D.
    Martin-Rodriguez, D.
    Mesonero, F.
    Zabana, Y.
    Crespo, A. Sanjose
    Sierra-Ausin, M.
    Caballol, B.
    Luengo, M. Curieses
    Giordano, A.
    Domenech, E.
    Gisbert, J. P.
    U REAL UC Study Grp ENEIDA
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1300 - i1302
  • [9] Upadacitinib promotes histological and endoscopic mucosal healing: Results from the Upadacitinib Ulcerative Colitis Phase 3 program
    Peyrin-Biroulet, L.
    Siegel, C. A.
    Tanida, S.
    Torres, E.
    Bossuyt, P.
    Dubinsky, M. C.
    Baert, F.
    Zhou, W.
    Klaff, J.
    Berg, S.
    Laroux, F. S.
    Gonzalez, Y. S.
    Yao, X.
    Zhou, Q.
    Reinisch, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 166 - 168
  • [10] Upadacitinib Promotes Histologic and Endoscopic Mucosal Healing: Results from the Upadacitinib Ulcerative Colitis Phase 3 Program
    Peyrin-Biroulet, L.
    Siegel, C.
    Tanida, S.
    Bossuyt, P.
    Torres, E.
    Dubinsky, M.
    Baert, F.
    Zhou, W.
    Klaff, J.
    Berg, S.
    Laroux, F. S.
    Gonzalez, Y. Sanchez
    Yao, X.
    Zhou, Q.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I477 - I478
12345